Radiopharm Theranostics Ltd ADR (RADX)

$16.19 +10.59 (189.11%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 10,245
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It develops RAD 204, a programmed death-ligand 1 (PD-L1) for the treatment of non-small cell lung cancer (NSCLC); RAD 202, a human epidermal growth factor receptor 2 (HER2) to treat breast cancer and other solid tumors; and RAD 301, a diagnostic radiopharmaceutical targeting avß6 integrin in pancreatic ductal adenocarcin...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9824 5254
Fax: 61 3 9822 7735
Address:
62 Lygon Street, Level 3, Carlton, Australia
RadioIsotope25
RadioIsotope25 Aug. 23 at 9:31 PM
$RADX Sanofi bought Ablynx for their nanobodies same as her2 and pdl1 at RADX. https://youtu.be/BFUvkW1FN7Y?si=OpC60_Kq7xasirWC
1 · Reply
Manpreet00
Manpreet00 Aug. 22 at 11:31 PM
$RADX when does the data come out
2 · Reply
RadioIsotope25
RadioIsotope25 Aug. 22 at 5:31 PM
$RADX Per ChatGPT if RAD101 has good data and if either pdl1 or her2 has good data. Company worth on buyout $500 million to $2 billion That’s 10-40 times current market cap. Just based off current shares outstanding.
1 · Reply
RadioIsotope25
RadioIsotope25 Aug. 22 at 4:54 PM
$RADX Bullish signal skipping dose level. Data out this quarter
0 · Reply
RadioIsotope25
RadioIsotope25 Aug. 22 at 2:43 PM
Fade before next rally.. allowing flippers to restock their positions. pump fake sell off $RADX
1 · Reply
RadioIsotope25
RadioIsotope25 Aug. 22 at 1:36 PM
$RADX Same float - expecting move like this on good solid data.
2 · Reply
RadioIsotope25
RadioIsotope25 Aug. 22 at 12:51 PM
$RADX Lantheus bought more at $11.70 in the first quarter. Worth that minimum. All this movement under that price is mispriced stock action. Lantheus is the crème de la crème in Radiopharma. This could be at $35 dollars in October. Even at $35 the market cap is still small compared to Clarity or Telix. Jones isn’t far off with this prediction at $30. Dealflow insane in this niche. $PBYI $AVDL $IOVA
1 · Reply
biospeculator
biospeculator Aug. 22 at 11:53 AM
$RADX From a technical standpoint (I was highly trained in a nearby beach bar), the stock is building a higher base. If the $6 base can hold, technical analysis points to a run in the $16-$24 area. My guess (based on three rumrunners) is that RAD 101 trial results will take us there. It is obvious we are and have been under institutional/hedge fund accumulation. GLTA
1 · Reply
RadioIsotope25
RadioIsotope25 Aug. 22 at 2:37 AM
$RADX Biotech’s with LU-177 drugs that were acquired. Radiopharm has a pipeline flush of them and ceo is ex- Novartis. $MNPR $LNTH $CLRB
1 · Reply
Cinematix
Cinematix Aug. 22 at 12:24 AM
$RADX was hoping to get more of this under $5. Can I get a dip to 4.89? Will just have to average up from here on out.
0 · Reply
Latest News on RADX
No data available.
RadioIsotope25
RadioIsotope25 Aug. 23 at 9:31 PM
$RADX Sanofi bought Ablynx for their nanobodies same as her2 and pdl1 at RADX. https://youtu.be/BFUvkW1FN7Y?si=OpC60_Kq7xasirWC
1 · Reply
Manpreet00
Manpreet00 Aug. 22 at 11:31 PM
$RADX when does the data come out
2 · Reply
RadioIsotope25
RadioIsotope25 Aug. 22 at 5:31 PM
$RADX Per ChatGPT if RAD101 has good data and if either pdl1 or her2 has good data. Company worth on buyout $500 million to $2 billion That’s 10-40 times current market cap. Just based off current shares outstanding.
1 · Reply
RadioIsotope25
RadioIsotope25 Aug. 22 at 4:54 PM
$RADX Bullish signal skipping dose level. Data out this quarter
0 · Reply
RadioIsotope25
RadioIsotope25 Aug. 22 at 2:43 PM
Fade before next rally.. allowing flippers to restock their positions. pump fake sell off $RADX
1 · Reply
RadioIsotope25
RadioIsotope25 Aug. 22 at 1:36 PM
$RADX Same float - expecting move like this on good solid data.
2 · Reply
RadioIsotope25
RadioIsotope25 Aug. 22 at 12:51 PM
$RADX Lantheus bought more at $11.70 in the first quarter. Worth that minimum. All this movement under that price is mispriced stock action. Lantheus is the crème de la crème in Radiopharma. This could be at $35 dollars in October. Even at $35 the market cap is still small compared to Clarity or Telix. Jones isn’t far off with this prediction at $30. Dealflow insane in this niche. $PBYI $AVDL $IOVA
1 · Reply
biospeculator
biospeculator Aug. 22 at 11:53 AM
$RADX From a technical standpoint (I was highly trained in a nearby beach bar), the stock is building a higher base. If the $6 base can hold, technical analysis points to a run in the $16-$24 area. My guess (based on three rumrunners) is that RAD 101 trial results will take us there. It is obvious we are and have been under institutional/hedge fund accumulation. GLTA
1 · Reply
RadioIsotope25
RadioIsotope25 Aug. 22 at 2:37 AM
$RADX Biotech’s with LU-177 drugs that were acquired. Radiopharm has a pipeline flush of them and ceo is ex- Novartis. $MNPR $LNTH $CLRB
1 · Reply
Cinematix
Cinematix Aug. 22 at 12:24 AM
$RADX was hoping to get more of this under $5. Can I get a dip to 4.89? Will just have to average up from here on out.
0 · Reply
RadioIsotope25
RadioIsotope25 Aug. 21 at 8:03 PM
$RADX Pdl-1 positive solid tumor out this quarter So will be out now to end of Sept. (by q3)
1 · Reply
neangewo
neangewo Aug. 21 at 6:05 PM
$RADX Based on volume, looks like an institution may have gotten into buy mode yesterday? Today looks like probably mostly all retail. Suck that it’s retracing. but volume is a lot lower than yesterday, which is a good sign it will probably be short-lived.
2 · Reply
Lalalilala
Lalalilala Aug. 21 at 5:51 PM
$RADX I've only been here since yesterday, but can someone explain to me why the daily trading is so low? Little interest, or are people already invested and are patiently waiting for the news to arrive? Little-known biotechnology that is still only in the clinical phase? It's a market that seems to generate a lot of money when the various clinical phases are completed, right? I've rarely seen a biotech where the daily trading is between 30,000 and 40,000 shares at most. Good luck to all!
3 · Reply
outlawinvestor1
outlawinvestor1 Aug. 21 at 3:32 PM
$RADX nice table of historical comps in radiopharm. we’re super early here! $NVS $BMY $LNTH $CATX
1 · Reply
RadioIsotope25
RadioIsotope25 Aug. 21 at 2:21 PM
$RADX Here’s my prediction. Stock will go up one day just like yesterday maybe a little more. News will break in Australia good data on 1 or 2 of the assets. Stock will double to triple and these guys thinking it’s risk less arbitrage will be crushed. I was in Race Oncology on ASX when it went from 3 cents to $4.00 per share. Aussies are light weights they undervalue then they extremely overvalue news! You will see.
0 · Reply
RadioIsotope25
RadioIsotope25 Aug. 21 at 2:09 PM
$RADX ADR arb traders are going to get crushed here. Lantheus bought more at $11.70 in January.
0 · Reply
RadioIsotope25
RadioIsotope25 Aug. 21 at 2:06 PM
$RADX Zero borrow again some shorts used it this morning. Now they aren’t looking so good!😊
0 · Reply
_www_larval_com_
_www_larval_com_ Aug. 21 at 2:02 PM
$RADX has reverted 9% higher to -4% (~38Kv) a moment ago, follow for more volatility.
0 · Reply
RadioIsotope25
RadioIsotope25 Aug. 21 at 1:50 PM
$RADX
0 · Reply
outlawinvestor1
outlawinvestor1 Aug. 21 at 1:47 PM
$RADX the people who are selling today will regret it by the end of the year. starting with relatively huge volume today though!
1 · Reply
RadioIsotope25
RadioIsotope25 Aug. 21 at 1:47 PM
$RADX Looking like Monopar did before it went vertical.
0 · Reply
RADX_enjoyer
RADX_enjoyer Aug. 21 at 1:46 PM
$RADX LMAO already trotting towards green. There's nothing available to push this down with https://fintel.io/ss/us/radx
0 · Reply